Suvorexant | CAS No. 1030377-33-3

Suvorexant

Basic Information

View in Editor

CAS Number

1030377-33-3

Molecular Formula

C23H23ClN6O2

Molecular Weight

450.93 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Dyes and Pigments Organic Dyes

Fine Chemicals Surfactants Anionic Surfactants

Agricultural Chemicals Pesticides Herbicides

Laboratory Chemicals Research Chemicals Biochemical Reagents

Basic Physical Properties

Melting Point

153 ºC

SMILES

View in Editor

Cc1ccc(c(c1)C(=O)N1CCN(CC[C@H]1C)c1oc2c(n1)cc(cc2)Cl)n1nccn1

InChI

InChI=1S/C23H23ClN6O2/c1-15-3-5-20(30-25-8-9-26-30)18(13-15)22(31)29-12-11-28(10-7-16(29)2)23-27-19-14-17(24)4-6-21(19)32-23/h3-6,8-9,13-14,16H,7,10-12H2,1-2H3/t16-/m1/s1

InChIKey

JYTNQNCOQXFQPK-MRXNPFEDSA-N

LogP

4.111320000000003

Topological Polar Surface Area

80.29 Å²

Hydrogen Bond Donor/Acceptor

0 / 8

Complexity

664

Synonyms & References

English

(R)-(4-(5-Chlorobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone
Suvorexant MK4305
MK 4305
MK-4305
Suvorexant (MK-4305)
[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone
5-Chloro-2-[(5R)-5-methyl-4-[5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl]-1,4-diazepan-1-yl]-1,3-benzoxazole
Suvorexant
[(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone
[(R)-4-(5-chlorobenzooxazol-2-yl)-7-methyl-[1,4]diazepan-1-yl](5-methy
5-chloro-2-{(5R)-5-methyl-4-[5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl]-1,4-diazepan-1-yl}-1,3-benzoxazole
Belsomra?
DORA-analogue
EOS-61934
SUVOREXABT
MK-4305 (Suvorexant)
Synonyms Suvorexant
Suvorexant (with 4 ints.)
BELSOMRA
MK4305
081L192FO9
C23H23ClN6O2
((7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone
(R)-(4-(5-chlo
(R)-(4-(5-chlorobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone

MDL Number

MFCD22377755

FAQ

What is Suvorexant (CAS: 1030377-33-3)?

Suvorexant (CAS: 1030377-33-3) is a medication used to treat insomnia. It is a selective orexin receptor antagonist. It has a chemical formula C22H23FN6O2 and is characterized by its ability to reduce the time it takes to fall asleep and improve overall sleep quality.

What are the main uses of Suvorexant (CAS: 1030377-33-3)?

Suvorexant (CAS: 1030377-33-3) is primarily used to treat insomnia. It is prescribed to individuals who have trouble falling asleep or staying asleep, and it helps in improving the continuity and quality of sleep.

Is Suvorexant (CAS: 1030377-33-3) safe?

Suvorexant (CAS: 1030377-33-3) is generally considered safe when used as directed. However, it may cause side effects such as dizziness, headache, and daytime sleepiness. It is important to follow the prescribed dosage and consult a healthcare provider if any adverse reactions occur.

How should Suvorexant (CAS: 1030377-33-3) be stored?

Suvorexant (CAS: 1030377-33-3) should be stored at room temperature, between 15°C and 25°C (59°F and 77°F). It should be protected from moisture and light. Keep the medication in a tightly sealed container to maintain its efficacy and safety.